thanks CP while i agree exosomes could hold great potential it might be a little late to the game to save current shareholders from pending RS. a little more than 3 weeks out. only a deal will prevent this from occurring. for a team that doesn't operate with any sense of urgency it's likely that they won't close anything soon. although given the moderate price improvement we can hope that they do a 3:1 and not the max 5:1